Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Miki Naito is a pioneering urologic surgeon whose research focuses on advancing robotic surgery for the treatment of urologic cancers. Her work has been instrumental in evaluating the safety and effectiveness of the hinotori™ Surgical Robot System, a next-generation platform for procedures such as robot-assisted radical prostatectomy (RARP) and partial nephrectomy. Dr. Naito’s studies, including a real-world clinical assessment of hinotori (cited 8 times), have provided critical evidence supporting its adoption in Japan. She has also made significant contributions to improving patient outcomes, notably identifying predictors of long-term postoperative urinary incontinence after RARP through propensity-matched analyses (6 citations). Her research extends to comparative effectiveness, demonstrating the benefits of robotic adrenalectomy over laparoscopic approaches (3 citations), and to quality improvement, showing that preoperative multidisciplinary team meetings reduce positive surgical margins in prostate cancer (2 citations). Additionally, Dr. Naito has addressed patient comfort with a randomized trial on open-ended urinary catheters to prevent catheter-related bladder discomfort (1 citation). Her work, published in high-impact journals, is shaping the future of minimally invasive urologic surgery.